NDF identified as the missing factor in gene activation
Scientists find the missing factor in gene activation...
List view / Grid view
Scientists find the missing factor in gene activation...
Researchers describe how a new drug is able to reduce the symptoms and activate the dormant neurons characteristic of Rett Syndrome...
Researchers have found mEAK-7 regulates the molecular process that dictates cell growth and human development...
Epigenomic analyses may lead to other unexpected findings and novel therapeutic drug targets for many diseases
Researchers are reporting an innovative new method to screen for potential cancer drugs...
A new technique that uses tiny elastic balls filled with fluorescent nanoparticles aims to expand the understanding of the mechanical forces that exist between cells...
Cancer researchers have measured systematically how efficient molecules are at suppressing the activity of a protein associated with prostate and other cancers...
Researchers have developed a new technique to restore retinal function in mice afflicted by a degenerative retinal disease, retinitis pigmentosa...
High levels of cytoskeleton-associated protein 4 (CKAP4) have been identified in the blood of patients with lung cancer.
Researchers have carried out the largest genomic analysis of patients with SMM to explain the biology of the disease and how it unfolds through time...
Scientists have successfully overcome the persistent cell rejection that has hitherto plagued attempts to introduce neural stem cells to replace damaged tissue in pigs.
Researchers create eye neuron network model to study retinal diseases, possible treatment options...
New findings demonstrate that there may be ways to address blood-brain barrier dysfunction in epilepsy...
Researchers found that the type of brain cell afflicted in Parkinson’s-related brain disorders dictates which pathological form of α-synuclein (α-syn) protein becomes the disease culprit.
Scientists in Japan have discovered a promising new biomarker – cytoskeleton-associated protein 4 (CKAP4) – for lung cancer, potentially transforming the way the disease is diagnosed and treated.